retatrutide clinical trial sign up New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats retatrutide clinical trial sign up

Baseline labs help establish your individual thyroid set point and guide monitoring frequency

Patients should never share pens, should use a new needle for each injection, and should not store pens with needles attached

Since studies suggest that GLP-1 may have a circadian rhythm release pattern, losing sleep, even over a short period, may disturb GLP-1 secretion

The research team developed a model to predict a drug's effect in advance by combining genetic variants with factors such as age, sex, drug type, and duration of use

Peak weight loss acceleration occurs during the dose-titration phase (weeks 4-20), with clinical trial data showing an average loss of 15-22% of baseline body weight by week 20

2025 Sep 17;393(11):107787